Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nonsteroidal aromatase inhibitor 1 (Compound 13h) effectively inhibits the enzyme CYP19A1 with an IC50 value of 0.09 nM. Due to its potent inhibitory activity, Nonsteroidal aromatase inhibitor 1 holds promise for research in the field of breast cancer [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Nonsteroidal aromatase inhibitor 1 (Compound 13h) effectively inhibits the enzyme CYP19A1 with an IC50 value of 0.09 nM. Due to its potent inhibitory activity, Nonsteroidal aromatase inhibitor 1 holds promise for research in the field of breast cancer [1]. |
In vitro | Treatment with nonsteroidal aromatase inhibitor 1 at concentrations ranging from 0.001 pM to 100 pM for 1 hour demonstrated significant aromatase inhibition, with an IC50 value of 0.09 nM, indicating excellent efficacy in inhibiting aromatase activity. Furthermore, at a concentration of 1 μM over 48 hours, the same treatment showed no significant effect on the growth of MCF-10A or MDA-MB-231 cells, implying minimal toxicity to normal breast tissue and limited off-target effects. This assessment was supported by both cell viability and cytotoxicity assays conducted on JEG-3, MCF-10A, and MDA-MB-231 cell lines. |
Molecular Weight | 368.39 |
Formula | C22H16N4O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nonsteroidal aromatase inhibitor 1 inhibitor inhibit